Invesco’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
Other funds holding APGE
Invesco's APGE Position: Q3 2026 in Review
Invesco sold out of Apogee Therapeutics (APGE) in Q3 2026, closing a stake of 39,317 shares — an estimated $5.22M sold.
Invesco first reported a position in APGE in Q3 2023 and held it in 12 quarters. The position peaked at $7.76M in Q3 2024. 3 funds tracked by Wall St. Rank hold APGE as of Q3 2026.
- Invesco reported no remaining Apogee Therapeutics position as of Q3 2026 after selling out during the quarter.
- Invesco sold 39,317 Apogee Therapeutics shares in Q3 2026, an estimated $5.22M.
- Invesco first reported a position in Apogee Therapeutics in Q3 2023 and held it in 12 quarters.
- Invesco's Apogee Therapeutics position peaked at $7.76M in Q3 2024.
- 3 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q3 2026.
Based on Invesco's 13F filing for Q3 2026, filed 12 Nov 2026.